Estrogen receptor beta agonists as anti-tumor and immune-modulatory agents in malignant glioma.

被引：0
|
作者：
Isaacs, Jordan Fredriksen [1 ]
Ravi, Divya [1 ]
Del Genio, Carmen L. [2 ]
Shalit, Zachary A. [1 ]
Micalizio, Glenn C. [1 ]
Gaur, Arti B. [1 ]
机构：
[1] Dartmouth Coll, Hanover, NH 03755 USA
[2] Dartmouth Hitchcock, Lebanon, NH USA
来源：
CANCER RESEARCH | 2021年 / 81卷 / 13期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1701
引用
收藏
页数：2
相关论文
共 50 条
  • [31] The Role of Anti-Tumor Necrosis Factor Receptor Agents in Cancer Survivors Revisited
    McClay, Edward F.
    SEMINARS IN ONCOLOGY, 2010, 37 (03) : 188 - 189
  • [32] IMMUNE RECEPTOR PIRB DELETION IMPACTS PANCREATIC CANCER GROWTH AND ANTI-TUMOR IMMUNE RESPONSE
    Scagliotti, Alessandro
    Curcio, Claudia
    Brugiapaglia, Silvia
    Tiberi, Giorgia
    Novelli, Francesco
    Takai, Toshiyuki
    Cappello, Paola
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A1487 - A1487
  • [33] Anti-tumor activity of the beta-adrenergic receptor antagonist propranolol in neuroblastoma
    Wolter, Jennifer K.
    Wolter, Nikolaus E.
    Blanch, Alvaro
    Partridge, Teresa
    Cheng, Lynn
    Morgenstern, Daniel A.
    Podkowa, Monika
    Kaplan, David R.
    Irwin, Meredith S.
    ONCOTARGET, 2014, 5 (01) : 161 - 172
  • [34] 1-BETA-D-ARABINOFURANOSYLCYTOSINE CONJUGATES OF CORTICOSTEROIDS AS POTENTIAL ANTI-TUMOR AGENTS
    HONG, CI
    NECHAEV, A
    WEST, CR
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1980, 21 (MAR): : 256 - 256
  • [35] 1-BETA-D-ARABINOFURANOSYLCYTOSINE CONJUGATES OF CORTICOSTEROIDS AS POTENTIAL ANTI-TUMOR AGENTS
    HONG, CI
    NECHAEV, A
    KIRISITS, AJ
    BUCHHEIT, DJ
    WEST, CR
    EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1983, 19 (08): : 1105 - 1112
  • [36] Delta-24-RGD Adenoviral Therapy Directs Oncolytic and Immune-Mediated Anti-Tumor Effects in Recurrent Malignant Glioma Patients
    Traylor, Jeffrey I.
    Kuo, John S.
    NEUROSURGERY, 2019, 84 (01) : E11 - E12
  • [37] TLR5 agonists enhance anti-tumor immunity and overcome resistance to immune checkpoint therapy
    Gonzalez, Caleb
    Williamson, Sarah
    Gammon, Seth T.
    Glazer, Sarah
    Rhee, Joon Haeng
    Piwnica-Worms, David
    COMMUNICATIONS BIOLOGY, 2023, 6 (01)
  • [38] APX005M, a humanized anti-CD40 antibody with strong immune-modulatory activities capable of tumor eradication in vivo
    Bjorck, Pia
    Filbert, Erin
    Yang, Xiaodong
    Trifan, Ovidiu C.
    CANCER RESEARCH, 2016, 76
  • [39] TLR5 agonists enhance anti-tumor immunity and overcome resistance to immune checkpoint therapy
    Caleb Gonzalez
    Sarah Williamson
    Seth T. Gammon
    Sarah Glazer
    Joon Haeng Rhee
    David Piwnica-Worms
    Communications Biology, 6
  • [40] A new anti-inflammatory and immune-modulatory peptide therapeutic improves glycaemic control and beta cell function in the db/db and STZ diabetes models
    Mogelsvang, S.
    Austin, D.
    Turner, A.
    Gelber, C.
    DIABETOLOGIA, 2013, 56 : S67 - S68
12345